Kerry Group Acquires Majority Stake in c-LEcta GmbH

Kerry Group to Acquire Lactase Enzyme Business from Chr. Hansen and Novozymes

December 14, 2023

Food & Beverage

Kerry Group PLC has agreed to acquire part of the global lactase enzyme business carved out from Chr. Hansen Holding A/S and Novozymes A/S for a total consideration of €150 million (subject to closing adjustments). The deal includes certain trade and assets of Chr. Hansen's global lactase business and 100% of Nuocheng Trillion Food (Tianjin) Co., Ltd.; the lactase business generated about €40 million in revenue in 2022 and the transaction is expected to close in the first half of 2024 subject to European Commission approval.

Kemin Industries Acquires CJ Youtell Biotech

September 23, 2025

Biotechnology

Kemin Industries has acquired CJ Youtell Biotech, the enzymes and fermentation subsidiary of CJ Bio, gaining full ownership of CJ Youtell’s fermentation plants and enzyme product portfolio. The acquisition adds fermentation capacity in Shandong and Hunan, China and expands Kemin’s global enzyme R&D, manufacturing and product offerings across animal feed, food, aquaculture and industrial end markets.

Accel-KKR Takes Majority Stake in Lemontech

June 28, 2019

Cloud & SaaS

Accel-KKR has made a majority investment in Lemontech, the Santiago-based legaltech SaaS provider, to accelerate the company's international expansion, product development and talent growth. As part of the transaction, Accel-KKR principals will join Lemontech’s board and provide strategic and operational support to scale the business across Latin America and beyond.

Canopy Biosciences Acquires Zellkraftwerk GmbH

April 29, 2019

Biotechnology

Canopy Biosciences acquired Leipzig-based Zellkraftwerk GmbH, adding Zellkraftwerk’s ChipCytometry multiplex cytometry instruments and related services to Canopy’s multi-omics portfolio. Concurrently, Ampersand Capital Partners made a strategic growth investment in Canopy to support geographic expansion and product/service scale-up across the US, Europe and Asia.

Arcline Investment Management Acquires Majority Interest in Akron Biotechnology

September 11, 2019

Biotechnology

Arcline Investment Management has acquired a majority interest in Akron Biotechnology LLC, a supplier of cGMP-compliant materials and services for cell and gene therapy manufacturers. Akron will remain led by founder and CEO Dr. Claudia Zylberberg, and Arcline plans to expand Akron's manufacturing capacity and pursue complementary acquisitions to build a platform in regenerative medicine.

CNL Strategic Capital Acquires Majority Stake in Vektek Holdings

May 10, 2022

Manufacturing

CNL Strategic Capital acquired a majority equity stake (with a concurrent debt investment) in Vektek Holdings, LLC from LFM Capital; terms were not disclosed. Vektek, headquartered in St. Joseph, Missouri, is a manufacturer of hydraulic and pneumatic workholding products serving automotive, aerospace, agriculture and other industrial end markets; the investment is intended to support continued product expansion and growth.